Rajnish Wellness

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685Z01033
  • NSEID:
  • BSEID: 541601
INR
0.39
-0.02 (-4.88%)
BSENSE

Aug 21, 03:30 PM

BSE+NSE Vol: 6927249

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

69.27 lacs (80.42%) Volume

Shareholding (Jun 2026)

FII

0.43%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

9.16%

Why is Rajnish Wellness Ltd falling/rising?

21-Aug-2026

As of 20-Aug, Rajnish Wellness Ltd's stock price is Rs. 0.41, unchanged from the previous session, with a year-to-date decline of 16.33% and a 56.38% drop over the past year. Despite a 78.97% increase in delivery volume, the stock remains below its moving averages, indicating a bearish trend.

As of 20-Aug, Rajnish Wellness Ltd's stock price is currently at Rs. 0.41, showing no change from the previous trading session. The stock has been underperforming in various time frames, with a year-to-date decline of 16.33% and a significant drop of 56.38% over the past year. Additionally, the stock has hit a new 52-week low of Rs. 0.39 today, indicating a downward trend.<BR><BR>The performance today has also been disappointing, as it underperformed its sector by 0.56%. Furthermore, Rajnish Wellness is trading lower than its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish sentiment among investors.<BR><BR>However, there is a slight positive note regarding investor participation, as the delivery volume increased by 78.97% compared to the 5-day average, indicating that some investors are still engaging with the stock. Despite this increase in participation, the overall indicators suggest that the stock is currently in a falling trend.

View full answer

Should I buy, sell or hold Rajnish Wellness Ltd?

15-Aug-2026

Who are in the management team of Rajnish Wellness?

14-Aug-2026

The management team of Rajnish Wellness includes Rajnishkumar Surendra Prasad Singh (Managing Director), Shalini Vijendra Mishra (Whole-time Director), and several Independent and Additional Directors, along with two Company Secretaries, bringing diverse expertise to the company's governance and strategy.

The management team of Rajnish Wellness includes the following individuals:<BR><BR>1. **Rajnishkumar Surendra Prasad Singh** - Managing Director<BR>2. **Shalini Vijendra Mishra** - Whole-time Director and also serves as a Non-Executive Director<BR>3. **Abhinandan Ashok Kumar Paliwal** - Independent Director<BR>4. **Madhukar Devappa Imade** - Independent Director<BR>5. **Monam Kapoor** - Independent Director<BR>6. **Sanjjari Kashyap** - Additional Director<BR>7. **Swati Jain** - Additional Director<BR>8. **Saloni Mehra** - Additional Director<BR>9. **Heet Ashok Shah** - Company Secretary<BR>10. **Rajveer Singh** - Company Secretary<BR><BR>This team brings a diverse range of expertise to the company, contributing to its governance and strategic direction.

View full answer

What does Rajnish Wellness do?

14-Aug-2026

Rajnish Wellness Ltd sells consumer durables and ayurvedic personal care products, operating in the Pharmaceuticals & Biotechnology industry as a Micro Cap company. It was incorporated in 2015, became public in 2018, and reported net sales of 31 Cr and a net profit of 0 Cr for June 2026.

Overview: <BR>Rajnish Wellness Ltd is engaged in selling various products ranging from consumer durables to ayurvedic personal care products, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap company.<BR><BR>History: <BR>Rajnish Wellness Ltd was originally incorporated on June 13, 2015, as a Private Limited Company under the name "Rajnish Hot Deals Private Limited." It was converted into a Public Limited Company on February 01, 2018, and subsequently renamed to "Rajnish Wellness Limited" on February 09, 2018. The most recent quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 31 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 43 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 45 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.09 <BR>Return on Equity: -5.20% <BR>Price to Book: 0.42 <BR><BR>Contact Details: <BR>Address: Bldg No 3 Navijivan Comm Socie, 6 Th Floor Office No 10L Mumbai Maharashtra : 400008 <BR>Tel: 91-22-23065555 <BR>Email: info@rajnishwellness.com <BR>Website: http://www.rajnishwellness.com

View full answer

Who are the peers of the Rajnish Wellness?

14-Aug-2026

Peers of Rajnish Wellness include Shelter Pharma, Mangalam Drugs, Vista Pharma, and others. Rajnish Wellness has average management risk, below average growth, and a 1-year return of -57.29%.

Peers: The peers of Rajnish Wellness are Shelter Pharma, Mangalam Drugs, Vista Pharma, Parmax Pharma, ANG Lifesciences, Murae Organisor, Sandu Pharma, Chandra Bhagat, and JFL Life.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shelter Pharma, while Average management risk is found at Rajnish Wellness, Sandu Pharma, and JFL Life. Below Average management risk is present at Mangalam Drugs, Vista Pharma, Parmax Pharma, ANG Lifesciences, Chandra Bhagat, and the rest. Growth is rated as Good at Murae Organisor and Excellent at JFL Life, while Below Average growth is noted at Rajnish Wellness, Mangalam Drugs, Vista Pharma, Parmax Pharma, ANG Lifesciences, Sandu Pharma, and the rest. Capital Structure is rated as Excellent at Shelter Pharma, Good at Sandu Pharma, and Below Average at Rajnish Wellness, Mangalam Drugs, Vista Pharma, Parmax Pharma, ANG Lifesciences, Murae Organisor, Chandra Bhagat, and the rest.<BR><BR>Return Snapshot: Parmax Pharma has the highest 1-year return at 219.36%, while Mangalam Drugs has the lowest at -63.83%. Rajnish Wellness has a 1-year return of -57.29%, which is better than Mangalam Drugs but worse than Parmax Pharma. Additionally, peers with a negative six-month return include Murae Organisor, Sandu Pharma, and Mangalam Drugs.

View full answer

How big is Rajnish Wellness?

14-Aug-2026

As of 14th August, Rajnish Wellness Ltd has a market capitalization of 42.64 Cr and reported Net Sales of 168.20 Cr with a Net Profit loss of 5.43 Cr over the latest four quarters. Shareholder's Funds are 84.16 Cr and Total Assets are 91.28 Cr.

As of 14th August, Rajnish Wellness Ltd has a market capitalization of 42.64 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Rajnish Wellness reported Net Sales of 168.20 Cr. However, it experienced a loss of 5.43 Cr in Net Profit during the same period.<BR><BR>The latest annual reporting period for the balance sheet is March 2025. Shareholder's Funds stand at 84.16 Cr, while Total Assets are valued at 91.28 Cr.

View full answer

When is the next results date for Rajnish Wellness Ltd?

11-Aug-2026

The next results date for Rajnish Wellness Ltd is 13 August 2026.

The next results date for Rajnish Wellness Ltd is scheduled for 13 August 2026.

View full answer

Are Rajnish Wellness Ltd latest results good or bad?

01-Jun-2026

Rajnish Wellness Ltd's latest results show significant revenue growth but are overshadowed by a net loss of ₹4.70 crores and declining operating margins, indicating serious operational challenges and a concerning outlook for the company.

The latest results for Rajnish Wellness Ltd indicate significant challenges, despite a notable increase in revenue. In the quarter ending March 2026, the company reported net sales of ₹101.95 crores, reflecting a remarkable 338.68% growth quarter-on-quarter and a staggering 1,666.90% increase year-on-year. However, this topline growth is overshadowed by severe operational issues.<BR><BR>The company posted a net loss of ₹4.70 crores, which is a significant deterioration from the previous quarter's loss of ₹0.91 crores. This widening loss highlights ongoing profitability concerns. Additionally, the operating margin fell to -6.70%, marking the worst performance in at least seven quarters, and the profit after tax (PAT) margin was deeply negative at -4.61%.<BR><BR>Overall, while the revenue growth appears impressive, it comes at an unsustainable cost, raising serious questions about the company's operational viability. The combination of massive losses, collapsing margins, and minimal institutional support suggests that the latest results are more indicative of distress than success. Therefore, the outlook for Rajnish Wellness Ltd is concerning, and it may be viewed as a negative development for the company.

View full answer

Is Rajnish Wellness overvalued or undervalued?

18-Nov-2025

As of November 17, 2025, Rajnish Wellness is considered overvalued and risky, with a PE ratio of -738.43 and a year-to-date return of -44.06%, significantly underperforming compared to peers like Hindustan Unilever and Nestle India.

As of 17 November 2025, the valuation grade for Rajnish Wellness has moved from expensive to risky, indicating a significant deterioration in its perceived value. The company is currently assessed as overvalued. Key ratios highlight this concern, with a PE ratio of -738.43, an EV to EBITDA of -81.01, and a ROE of -0.13%. <BR><BR>When compared to peers, Rajnish Wellness stands out negatively against companies such as Hindustan Unilever, which has a PE ratio of 53.89, and Nestle India with a PE of 81.88. The stark contrast in valuation metrics underscores the challenges Rajnish Wellness faces in the market. Additionally, the company's stock has underperformed significantly, with a year-to-date return of -44.06% compared to the Sensex's positive return of 8.72%, reinforcing the notion of overvaluation in the current context.

View full answer

How has been the historical performance of Rajnish Wellness?

17-Nov-2025

Rajnish Wellness has experienced significant financial fluctuations, with net sales dropping from INR 76.68 crore in March 2024 to INR 48.56 crore in March 2025, alongside declines in profits and negative cash flow. Overall, the company is facing a challenging period marked by decreasing revenues and profits.

Answer:<BR>The historical performance of Rajnish Wellness shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>Rajnish Wellness experienced a decline in net sales from INR 76.68 crore in March 2024 to INR 48.56 crore in March 2025, following a notable increase from INR 25.03 crore in March 2023. The total operating income mirrored this trend, dropping to INR 48.56 crore in March 2025 from INR 76.68 crore in the previous year. The company reported no raw material costs, and the purchase of finished goods decreased to INR 46.33 crore in March 2025 from INR 76.54 crore in March 2024. Operating profit (PBDIT) fell to INR 0.52 crore in March 2025, down from INR 1.97 crore in March 2024, while profit before tax also decreased to INR 0.23 crore from INR 1.45 crore. Consequently, profit after tax dropped to INR 0.17 crore in March 2025 from INR 1.03 crore in the previous year. The company's total assets decreased to INR 91.28 crore in March 2025 from INR 106.26 crore in March 2024, and total liabilities also fell to INR 91.28 crore from INR 106.26 crore. Cash flow from operating activities was negative at INR -4.00 crore in March 2025, contrasting with a positive cash flow of INR 1.00 crore in March 2024. Overall, the financial performance of Rajnish Wellness reflects a challenging period with declining revenues and profits.

View full answer

Who are the top shareholders of the Rajnish Wellness?

17-Jul-2025

The top shareholders of Rajnish Wellness include promoter Rajnish Kumar Singh with 7.41%, individual investors holding 82.53%, and Skybridge Incap Advisory LLP as the largest public shareholder at 1.37%. The majority of shares are held by non-institutional investors, with no mutual fund holdings.

The top shareholders of Rajnish Wellness include Rajnish Kumar Singh, who is the promoter with the highest holding at 7.41%. The company also has a significant portion of individual investors holding 82.53% of the shares. Additionally, Skybridge Incap Advisory LLP is the highest public shareholder, holding 1.37%. There is one foreign institutional investor (FII) that holds 0.57% of the shares, while mutual funds do not hold any shares in the company. Overall, the majority of the shareholding is with non-institutional investors.

View full answer

What is the technical trend for Rajnish Wellness?

09-Jun-2025

As of June 6, 2025, Rajnish Wellness shows a bearish trend with weak strength, supported by bearish monthly indicators and daily moving averages, despite some mixed signals from the MACD and RSI.

As of 6 June 2025, the technical trend for Rajnish Wellness has changed from mildly bearish to bearish. The current stance is bearish with weak strength. The weekly MACD is mildly bullish, but the monthly MACD and KST are bearish, indicating a lack of strong upward momentum. The RSI shows no signal on the weekly chart while being bullish on the monthly, suggesting mixed signals. Both the weekly and monthly Bollinger Bands are bearish, reinforcing the downward trend. Daily moving averages are bearish, further supporting the negative outlook. Overall, the indicators suggest a prevailing bearish sentiment in the short to medium term.

View full answer

What is the bonus history of the Rajnish Wellness?

06-Jun-2025

Rajnish Wellness has a recent bonus history that includes a 2:1 bonus announced on July 21, 2022, and a 5:4 bonus issued on December 23, 2021, reflecting the company's commitment to rewarding shareholders.

Rajnish Wellness has a notable bonus history. The most recent bonus issue was a 2:1 bonus, which was announced with an ex-date of July 21, 2022, and a record date of July 22, 2022. Prior to that, the company issued a 5:4 bonus with an ex-date of December 23, 2021, and a record date of December 24, 2021. This indicates that Rajnish Wellness has been active in rewarding its shareholders through bonus issues in the recent past.

View full answer

Has Rajnish Wellness declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -186.06% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -2.41
  • The company has been able to generate a Return on Equity (avg) of 0.41% signifying low profitability per unit of shareholders funds
2

Risky - Negative EBITDA

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 42 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

45

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.09

stock-summary
Return on Equity

-5.29%

stock-summary
Price to Book

0.41

Revenue and Profits:
Net Sales:
31 Cr
(Quarterly Results - Jun 2026)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.36%
0%
-11.36%
6 Months
-15.22%
0%
-15.22%
1 Year
-57.61%
0%
-57.61%
2 Years
-89.54%
0%
-89.54%
3 Years
-97.01%
0%
-97.01%
4 Years
-96.5%
0%
-96.5%
5 Years
-45.83%
0%
-45.83%

Rajnish Wellness for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Submission Of Newspaper Clippings Of Un-Audited Financial Results For Quarter Ended 30Th June 2026

14-Aug-2026 | Source : BSE

Pursuant to Regulation 47 of SEBI (LODR) REGULATIONS 2015 newspaper clipplings for the un-audited financial results for the quarter ended 30-06-2026 published in the Active Times (English version) and Mumbai Lakshadeep (Marathi edition)

Board Meeting Outcome for Outcome Of Board Meeting Held Today On Thursday The 13Th August 2026

13-Aug-2026 | Source : BSE

Outcome of board meeting held on 13th August 2026 for quarterly results for 30-06-2026

Un-Audited Standalone Financial Results For The Quarter Ended 30Th June 2026

13-Aug-2026 | Source : BSE

Financial results of the Company for quarter ended on 30th June 2026 along with Limited Review Report of the statutory Auditor thereon

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Rajnish Wellness Ltd has announced 1:2 stock split, ex-date: 10 Jan 23

stock-summary
BONUS

Rajnish Wellness Ltd has announced 2:1 bonus issue, ex-date: 21 Jul 22

stock-summary
RIGHTS

Rajnish Wellness Ltd has announced 19:30 rights issue, ex-date: 03 Jun 25

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
61.07%
EBIT Growth (5y)
-186.06%
EBIT to Interest (avg)
-2.41
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.71
Tax Ratio
29.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.43%
ROCE (avg)
-3.09%
ROE (avg)
0.41%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
45
Price to Book Value
0.41
EV to EBIT
-3.83
EV to EBITDA
-3.84
EV to Capital Employed
0.35
EV to Sales
0.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.88%
ROE (Latest)
-5.29%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.43%)

Promoter with highest holding

Rajnish Kumar Singh (9.16%)

Highest Public shareholder

Jr Seamless Private Limited (1.3%)

Individual Investors Holdings

85.19%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -69.58% vs 338.68% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 102.55% vs -416.48% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31.01",
          "val2": "101.95",
          "chgp": "-69.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.05",
          "val2": "-6.83",
          "chgp": "100.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.12",
          "val2": "-4.70",
          "chgp": "102.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.16%",
          "val2": "-6.70%",
          "chgp": "6.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -50.89% vs 24.80% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -36.36% vs -32.31% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.56",
          "val2": "33.72",
          "chgp": "-50.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.04",
          "val2": "0.48",
          "chgp": "-108.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.23",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.28",
          "val2": "0.44",
          "chgp": "-36.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.24%",
          "val2": "1.42%",
          "chgp": "-1.66%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -6.97% vs -12.05% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -223.53% vs -32.00% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39.80",
          "val2": "42.78",
          "chgp": "-6.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.41",
          "val2": "0.61",
          "chgp": "-331.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.27",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.63",
          "val2": "0.51",
          "chgp": "-223.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.54%",
          "val2": "1.43%",
          "chgp": "-4.97%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 191.91% vs -36.67% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -3,800.00% vs -83.50% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "141.75",
          "val2": "48.56",
          "chgp": "191.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.22",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.27",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-6.29",
          "val2": "0.17",
          "chgp": "-3,800.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6.50%",
          "val2": "0.00%",
          "chgp": "-6.50%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
31.01
101.95
-69.58%
Operating Profit (PBDIT) excl Other Income
0.05
-6.83
100.73%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.12
-4.70
102.55%
Operating Profit Margin (Excl OI)
0.16%
-6.70%
6.86%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -69.58% vs 338.68% in Mar 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 102.55% vs -416.48% in Mar 2026

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
16.56
33.72
-50.89%
Operating Profit (PBDIT) excl Other Income
-0.04
0.48
-108.33%
Interest
0.00
0.23
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.28
0.44
-36.36%
Operating Profit Margin (Excl OI)
-0.24%
1.42%
-1.66%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -50.89% vs 24.80% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -36.36% vs -32.31% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
39.80
42.78
-6.97%
Operating Profit (PBDIT) excl Other Income
-1.41
0.61
-331.15%
Interest
0.00
0.27
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.63
0.51
-223.53%
Operating Profit Margin (Excl OI)
-3.54%
1.43%
-4.97%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -6.97% vs -12.05% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -223.53% vs -32.00% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
141.75
48.56
191.91%
Operating Profit (PBDIT) excl Other Income
-9.22
0.00
Interest
0.00
0.27
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-6.29
0.17
-3,800.00%
Operating Profit Margin (Excl OI)
-6.50%
0.00%
-6.50%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 191.91% vs -36.67% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is -3,800.00% vs -83.50% in Mar 2025

stock-summaryCompany CV
About Rajnish Wellness Ltd stock-summary
stock-summary
Rajnish Wellness Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Rajnish Wellness Limited was originally incorporated on June 13, 2015 as a Private Limited Company under the name and style of "Rajnish Hot Deals Private Limited". Subsequently, the Company was converted into a Public Limited Company on February 01, 2018 and was renamed to "Rajnish Wellness Limited" on February 09, 2018. The Company is currently engaged in the business of selling various products in the categories ranging from consumer durables to ayurvedic personal care products.
Company Coordinates stock-summary
Company Details
Bldg No 3 Navijivan Comm Socie, 6 Th Floor Office No 10L Mumbai Maharashtra : 400008
stock-summary
Tel: 91-22-23065555
stock-summary
info@rajnishwellness.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai